Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gattermann

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Blood|November 15, 1993
All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot studyC Aul, V Runde, N Gattermann
British Journal of Haematology|January 1, 1990
Two types of acquired idiopathic sideroblastic anaemia (AISA)N Gattermann, C Aul, W Schneider
Leukemia|December 1, 1993
Is acquired idiopathic sideroblastic anemia (AISA) a disorder of mitochondrial DNA?N Gattermann, C Aul, W Schneider
British Journal of Haematology|December 11, 2002
How frequent is mutation in the mitochondrial cytochrome c oxidase gene in patients with myelodysplastic syndromes?N Gattermann, M Wulfert, G Hofhaus
Klinische Wochenschrift|June 5, 1990
Refractory and relapsing Hodgkin's disease: role of high-dose chemotherapy with bone marrow transplantationM Thomas, N Gattermann, W Schneider
Leukemia & Lymphoma|January 1, 1995
Epidemiological and etiological aspects of myelodysplastic syndromesC Aul, N Gattermann, W Schneider
European Journal of Haematology|January 1, 1991
Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha 2bC Aul, N Gattermann, W Schneider
British Journal of Haematology|October 1, 1992
Age-related incidence and other epidemiological aspects of myelodysplastic syndromesC Aul, N Gattermann, W Schneider
Der Internist|December 31, 1997
[Therapy of transfusion hemochromatosis]C Aul, N Gattermann, M Jaeger
Blood|June 19, 2001
X chromosome inactivation ratios in female carriers of X-linked sideroblastic anemiaM Aivado, N Gattermann, S Bottomley
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Blood|November 15, 1993
All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot studyC Aul, V Runde, N Gattermann
British Journal of Haematology|January 1, 1990
Two types of acquired idiopathic sideroblastic anaemia (AISA)N Gattermann, C Aul, W Schneider
Leukemia|December 1, 1993
Is acquired idiopathic sideroblastic anemia (AISA) a disorder of mitochondrial DNA?N Gattermann, C Aul, W Schneider
British Journal of Haematology|December 11, 2002
How frequent is mutation in the mitochondrial cytochrome c oxidase gene in patients with myelodysplastic syndromes?N Gattermann, M Wulfert, G Hofhaus
Klinische Wochenschrift|June 5, 1990
Refractory and relapsing Hodgkin's disease: role of high-dose chemotherapy with bone marrow transplantationM Thomas, N Gattermann, W Schneider
Leukemia & Lymphoma|January 1, 1995
Epidemiological and etiological aspects of myelodysplastic syndromesC Aul, N Gattermann, W Schneider
European Journal of Haematology|January 1, 1991
Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha 2bC Aul, N Gattermann, W Schneider
British Journal of Haematology|October 1, 1992
Age-related incidence and other epidemiological aspects of myelodysplastic syndromesC Aul, N Gattermann, W Schneider
Der Internist|December 31, 1997
[Therapy of transfusion hemochromatosis]C Aul, N Gattermann, M Jaeger
Blood|June 19, 2001
X chromosome inactivation ratios in female carriers of X-linked sideroblastic anemiaM Aivado, N Gattermann, S Bottomley
Pageof 11